AUROBINDO PHARMA LTD. - 524804 - Unit III Of Eugia Pharma Specialities Ltd., Receives Warning Letter From US FDA

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer

1090.0000 -7.00 (-0.64%)

NSE Sep 26, 2025 15:31 PM

28.77% Fall from 52W High

Volume: 2.4M

Aurobindo Pharma Ltd.

16 Aug 2024

1090.00

-0.64%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Unit III Of Eugia Pharma Specialities Ltd., Receives Warning Letter …

BSE India

Intimation of receipt of Warning Letter from US FDA for Unit III of Eugia Pharma Specialities Limited, a wholly owned subsidiarity of the Company

More from Aurobindo Pharma Ltd.

Recommended

The new H1B fee: Who will it hurt the most?

The Baseline | 26 Sep 2025, 05:06PM

Five Interesting Stocks Today - September 26, 2025

The Baseline | 26 Sep 2025, 04:56PM

A deal is called off, increasing the chance for Aurobindo Pharma to be debt free